DavidWmScharpMD
General Surgery • APO, APTransplantation
President & CEO, Prodo Laboratories Chairman of the Board, Scharp Technologies Scientific Director, The Scharp-Lacy Research Institute
Dr. Scharp is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
32A Mauchly
APO, AP 96218Phone+1 949-727-1972
Education & Training
Washington University in St. Louis School of MedicineClass of 1970
Publications & Presentations
PubMed
- 27 citationsThe effect of pancreatic warm ischemia on islet isolation in rats and dogs.Michael P. Corlett, David W. Scharp
The Journal of Surgical Research. 1988-12-01 - 12 citationsPulsatile intravenous insulin therapy: the best practice to reverse diabetes complications?M. Reza Mirbolooki, George E. Taylor, Victor K. Knutzen, David W. Scharp, Robin J. Willcourt
Medical Hypotheses. 2009-09-01 - 200 citationsEffect of transplantation site on the results of pancreatic islet isografts in diabetic rats.Kemp Cb, Michael J. Knight, David W. Scharp, Walter F. Ballinger, Paul E. Lacy
Diabetologia. 1973-12-01
Grant Support
- Novel Thermal Reversible Polymer (TRG) For Human Islet Encapsulation And ImplantaNational Institute Of Diabetes And Digestive And Kidney Diseases2011
- Core--Human Islet IsolationNational Institute Of Diabetes And Digestive And Kidney Diseases1996–1997
- Clinical Islet TransplantationNational Center For Research Resources1996
- Clinical Trials On Human Islet TransplantationNational Institute Of Diabetes And Digestive And Kidney Diseases1988–1993
- Clinical Islet Transplantation In Diabetes MellitusNational Center For Research Resources1990
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
